Article
Genetic variation in ABCB5 associates with risk of hepatocellular carcinoma.
Journal of cellular and molecular medicine - 1 Sept 2020
Leung Idy C-Y, Chong Charing C-N, Cheung Tan T, Yeung Philip C, Ng Kelvin K-C, Lai Paul B-S, Chan Stephen L, Chan Anthony W-H, Tang Patrick M-K, Cheung Siu T
Abstract excerpt
Expression of ATP-binding cassette B5 (ABCB5) has been demonstrated to confer chemoresistance, enhance cancer stem cell properties and associate with poor prognosis in hepatocellular carcinoma (HCC). The aim of this study was to evaluate the genetic variations of ABCB5 in HCC patients with reference to healthy individuals and the clinicopathological significance. A pilot study has examined 20 out of 300 pairs HCC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
